Literature DB >> 28755978

Duration of isoflurane-based surgical anesthesia determines severity of brain injury and neurological deficits after a transient focal ischemia in young adult rats.

Nikhil Gaidhani1, Fen Sun1, Derek Schreihofer1, Victor V Uteshev2.   

Abstract

Tremendous efforts and funds invested in discovery of novel drug treatments for ischemic stroke have so far failed to deliver clinically efficacious therapies. The reasons for these failures are not fully understood. An indiscriminate use of isoflurane-based surgical anesthesia with or without nitrous oxide may act as an unconstrained, untraceable source of data variability, potentially causing false-positive or false-negative results. To test this hypothesis, a common transient suture middle cerebral artery occlusion (tMCAO) model of ischemic stroke in young adult male rats was used to determine the impact of a typical range of anesthesia durations required for this model on data variability (i.e., infarct volume and neurological deficits). The animals were maintained on spontaneous ventilation. The study results indicated that: (1) Variable duration of isoflurane anesthesia prior, during and after tMCAO is a significant source of data variability as evidenced by measurements of infarct volume and neurological deficits; and (2) Severity of brain injury and neurological deficits after tMCAO is inversely related to the duration of isoflurane anesthesia: e.g., in our study, a 90min isoflurane anesthesia nearly completely protected brain tissues from tMCAO-induced injury and thus, would be expected to obscure the effects of stroke treatments in pre-clinical trials. To elevate transparency, rigor and reproducibility of stroke research and minimize undesirable effects of isoflurane on the outcome of novel drug testing, we propose to monitor, minimize and standardize isoflurane anesthesia in experimental surgeries and make anesthesia duration a required reportable parameter in pre-clinical studies. Specifically, we propose to adopt 20-30min as an optimal anesthesia duration that both minimizes neuroprotective effects of isoflurane and permits a successful completion of surgical procedures in a suture tMCAO model of ischemic stroke in rodents. As the mechanisms and neuroprotective, metabolic and immune effects of general anesthesia are not fully understood, the results of this study cannot be blindly generalized to other anesthetics, animal species and experimental models.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anesthesia; Ischemic; Isoflurane; MCAO; Middle cerebral artery occlusion; Stroke

Mesh:

Substances:

Year:  2017        PMID: 28755978     DOI: 10.1016/j.brainresbull.2017.07.018

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  9 in total

1.  TGF-β2/Smad3 Signaling Pathway Activation Through Enhancing VEGF and CD34 Ameliorates Cerebral Ischemia/Reperfusion Injury After Isoflurane Post-conditioning in Rats.

Authors:  Li Peng; Jiangwen Yin; Sheng Wang; Mingyue Ge; Ziwei Han; Yan Wang; Meng Zhang; Liping Xie; Yan Li
Journal:  Neurochem Res       Date:  2019-09-25       Impact factor: 3.996

2.  Harmonization of lateral fluid-percussion injury model production and post-injury monitoring in a preclinical multicenter biomarker discovery study on post-traumatic epileptogenesis.

Authors:  Xavier Ekolle Ndode-Ekane; Cesar Santana-Gomez; Pablo M Casillas-Espinosa; Idrish Ali; Rhys D Brady; Gregory Smith; Pedro Andrade; Riikka Immonen; Noora Puhakka; Matthew R Hudson; Emma L Braine; Sandy R Shultz; Richard J Staba; Terence J O'Brien; Asla Pitkänen
Journal:  Epilepsy Res       Date:  2019-01-18       Impact factor: 3.045

Review 3.  Perioperative stroke: A perspective on challenges and opportunities for experimental treatment and diagnostic strategies.

Authors:  Xia Jin; Peiying Li; Dominik Michalski; Shen Li; Yueman Zhang; Jukka Jolkkonen; Lili Cui; Nadine Didwischus; Wei Xuan; Johannes Boltze
Journal:  CNS Neurosci Ther       Date:  2022-02-27       Impact factor: 5.243

Review 4.  Defining and Managing Pain in Stroke and Traumatic Brain Injury Research.

Authors:  Christina M Larson; George L Wilcox; Carolyn A Fairbanks
Journal:  Comp Med       Date:  2019-12-20       Impact factor: 0.982

5.  Treatment duration affects cytoprotective efficacy of positive allosteric modulation of α7 nAChRs after focal ischemia in rats.

Authors:  Nikhil Gaidhani; Victor V Uteshev
Journal:  Pharmacol Res       Date:  2018-09-08       Impact factor: 7.658

Review 6.  Anesthetic management of unruptured intracranial aneurysms: a qualitative systematic review.

Authors:  Shooka Esmaeeli; Juan Valencia; Lauren K Buhl; Andres Brenes Bastos; Sogand Goudarzi; Matthias Eikermann; Corey Fehnel; Richard Pollard; Ajith Thomas; Christopher S Ogilvy; Shahzad Shaefi; Ala Nozari
Journal:  Neurosurg Rev       Date:  2021-01-07       Impact factor: 2.800

Review 7.  Developing a standardized system of exposure and intervention endpoints for isoflurane in preclinical stroke models.

Authors:  Tyler C Hillman; Nathanael Matei; Jiping Tang; John H Zhang
Journal:  Med Gas Res       Date:  2019 Jan-Mar

Review 8.  Recent advances in the neuroprotective effects of medical gases.

Authors:  Yue-Zhen Wang; Ting-Ting Li; Hong-Ling Cao; Wan-Chao Yang
Journal:  Med Gas Res       Date:  2019 Apr-Jun

9.  Validity and Efficacy of Methods to Define Blood Brain Barrier Integrity in Experimental Ischemic Strokes: A Comparison of Albumin Western Blot, IgG Western Blot and Albumin Immunofluorescence.

Authors:  Maximilian Franke; Michael Bieber; Guido Stoll; Michael Klaus Schuhmann
Journal:  Methods Protoc       Date:  2021-03-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.